Aktis Oncology, Inc. (AKTS) SEC filings and CIK.
AKTS’s SEC Central Index Key (CIK) is 0002035832, or 2035832 without leading zeros. The SEC’s ticker file lists it as Aktis Oncology, Inc..
- Ticker
- AKTS
- CIK
- 0002035832
- Other tickers
- None
- Insider transactions, Q3 2026
- 17
Insider trading
In Q3 2026, insiders at Aktis Oncology, Inc. reported 17 non-derivative transactions on 5 Forms 3, 4 and 5, including 0 open-market purchases and 11 sales. See every AKTS insider transaction →
Recent filings we observed
No filings for this CIK appear in our current observation window. The full history is available from the filings endpoint below and on SEC.gov.
Get AKTS SEC data through the API
curl "https://sec-api.dev/api/v1/filings?cik=2035832&limit=10" \
-H "Authorization: Bearer $SEC_API_KEY"curl "https://sec-api.dev/api/v1/companies/2035832" \
-H "Authorization: Bearer $SEC_API_KEY"curl "https://sec-api.dev/api/v1/facts/2035832?taxonomy=us-gaap&concept=Revenues&limit=10" \
-H "Authorization: Bearer $SEC_API_KEY"Ticker to CIK API · SEC filings API · Aktis Oncology, Inc. on SEC.gov
Questions
What is AKTS’s CIK number?
AKTS’s SEC Central Index Key (CIK) is 0002035832, or 2035832 without leading zeros. The SEC’s ticker file lists it as Aktis Oncology, Inc..
How do I find Aktis Oncology, Inc.’s 10-K?
Request /api/v1/filings?cik=2035832&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.
Plain-text version for agents and LLMs: /companies/akts.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.